EUVIMEDEUVIMED entdecken
Crossref

Nanoparticle-Mediated Cosilencing of Drug Resistance and Compensatory Genes Enhances Lung Cancer Therapy

Dhananjay Suresh iD, Soumavo Mukherjee, Ajit Zambre, Shreya Ghoshdastidar, Sairam Yadavilli, Karamkolly R Rekha, Anandhi Upendran iD, Raghuraman Kannan iD

ACS Nano · 2025

DOI: 10.1021/acsnano.4c12318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Dhananjay Suresh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Missouri, Columbia, Missouri 65212, United States. Hauptthemen laut MEDLINE: Lung Neoplasms, Drug Resistance, Neoplasm, Receptor Protein-Tyrosine Kinases, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: NCI NIH HHS, NIBIB NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsDrug Resistance, NeoplasmReceptor Protein-Tyrosine KinasesCarcinoma, Non-Small-Cell LungNanoparticlesProto-Oncogene ProteinsRNA, Small InterferingAntineoplastic AgentsHumansAnimalsMiceAxl Receptor Tyrosine KinaseCell Line, TumorProtein Kinase InhibitorsMice, Nude

Stichwörter der Autor:innen

AXLFN14drug-resistancegelatinlung cancernanoparticlesiRNA

Substanzen

Receptor Protein-Tyrosine KinasesAxl Receptor Tyrosine KinaseProto-Oncogene ProteinsRNA, Small InterferingProtein Kinase InhibitorsAntineoplastic AgentsAXL protein, human

Autor:innen und Institutionen

  • Department of Bioengineering, University of Missouri, Columbia, Missouri 65212, United States.
  • Department of Radiology, University of Missouri, Columbia, Missouri 65212, United States.
  • Department of Medical Pharmacology & Physiology, University of Missouri, Columbia, Missouri 65212, United States.
  • Ellis Fischel Cancer Center, School of Medicine, University of Missouri, Columbia, Missouri 65212, United States.

ORCID-Profile: Dhananjay Suresh, Anandhi Upendran, Raghuraman Kannan

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • National Cancer Institute

Zitieren

APA

Suresh, D., Mukherjee, S., Zambre, A., Ghoshdastidar, S., Yadavilli, S., Rekha, K. R., Upendran, A., & Kannan, R. (2025). Nanoparticle-Mediated Cosilencing of Drug Resistance and Compensatory Genes Enhances Lung Cancer Therapy. ACS Nano. https://doi.org/10.1021/acsnano.4c12318

Vancouver

Suresh D, Mukherjee S, Zambre A, Ghoshdastidar S, Yadavilli S, Rekha KR, et al. Nanoparticle-Mediated Cosilencing of Drug Resistance and Compensatory Genes Enhances Lung Cancer Therapy. ACS Nano. 2025. doi:10.1021/acsnano.4c12318

BibTeX
@article{Suresh2025,
  author = {Suresh, Dhananjay and Mukherjee, Soumavo and Zambre, Ajit and Ghoshdastidar, Shreya and Yadavilli, Sairam and Rekha, Karamkolly R and Upendran, Anandhi and Kannan, Raghuraman},
  title = {Nanoparticle-Mediated Cosilencing of Drug Resistance and Compensatory Genes Enhances Lung Cancer Therapy},
  journal = {ACS Nano},
  year = {2025},
  doi = {10.1021/acsnano.4c12318}
}
Kostenlos starten →